XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
  IBS
  Liver
  GERD
  Constipation
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Gastroenterology Channel
subscribe to Gastroenterology newsletter

Latest Research : Gastroenterology

   DISCUSS   |   EMAIL   |   PRINT
Benefits of Polyflex Esophageal Stents For Treating Refractory Benign Esophageal Strictures
May 25, 2006, 12:59, Reviewed by: Dr. Priya Saxena

“The results of the study illustrate the potential benefits of using the Polyflex Esophageal Stent to reduce the number of endoscopic interventions in patients with resistant benign gastroesophageal anastomotic strictures. Having to undergo serial dilations is problematic for patients and this study should help raise awareness among physicians that the use of the Polyflex temporary stent may provide a favorable alternative for some patients.”

 
Boston Scientific Corporation today announced the results of two studies on the use of its Polyflex® Esophageal Stent, a fully covered, self-expanding, silicone-coated temporary stent designed for use in patients with refractory benign or malignant esophageal strictures. The results of these studies were presented at the Digestive Disease Week® (DDW®) meeting in Los Angeles.

Benign gastroesophageal anastomotic strictures (AS) are a post-surgical complication that occur in up to 43 percent of patients who undergo transhiatal esophagectomy (THE), the removal of the esophagus through the diaphragm without opening the chest. These strictures are a narrowing of the esophageal passageway which may be caused by scar tissue or inflammation. Management of AS may require extensive periods of serial endoscopic dilation typically performed with a balloon. Repeated dilation poses significant risk, cost and patient inconvenience.

A study led by James Barthel, M.D., of the University of South Florida College of Medicine, examined the placement of the Polyflex Stent to determine whether its use could reduce the number of endoscopic interventions required by patients to manage persistent AS. This five-patient study found that the Polyflex Stent reduced the number of endoscopic interventions and allowed patients to extend the average time without repeated dilation from 6.8 to 76 days.

“The results of the study illustrate the potential benefits of using the Polyflex Esophageal Stent to reduce the number of endoscopic interventions in patients with resistant benign gastroesophageal anastomotic strictures,” said Dr. Barthel. “Having to undergo serial dilations is problematic for patients and this study should help raise awareness among physicians that the use of the Polyflex temporary stent may provide a favorable alternative for some patients.”

A second Polyflex Stent study, reported at DDW by Kulwinder S. Dua, M.D., and Rajesh Santharam, M.D., of the Medical College of Wisconsin, investigated the effectiveness of using the Polyflex Stent to reduce the number of dilations to relieve dysphagia caused by resilient non-peptic benign esophageal strictures.
Dysphagia, difficulty or discomfort when swallowing, is one of the most common symptoms in patients with esophageal strictures. These types of strictures can have a severe impact on a patient’s quality of life and can lead to complications such as aspiration, weight loss and malnutrition. In the most severe refractory cases, patients may even require balloon or rigid dilations as frequently as every few weeks to relieve symptoms.
In the study, researchers determined that the Polyflex® Stent can be deployed and removed in the majority of patients with resilient benign esophageal strictures. Removal after four weeks in place can result in long-term relief of dysphagia in over 40 percent of patients (median follow up 54 weeks) without further re-interventions. Other patients preferred long-term re-stenting rather than going back to their baseline approach of repeated dilations or undergoing surgery. Further large scale prospective studies will be required to determine the optimal duration for keeping the stent in place before removal and to determine if the stricture characteristics and etiology can predict the response rates. As the procedure carries risks, it should be considered in carefully selected patients.
“We are pleased that the results of this study illustrate that patients have another option besides repeated dilation,” said Dr. Dua. “With the Polyflex Stent, many patients experienced long-term relief without having to undergo further dilation or surgery.”

Esophageal stenting is a less-invasive procedure in which a stent is inserted via a delivery system into the esophagus and placed across malignant or refractory benign strictures to maintain the natural opening. The Polyflex Esophageal Stent System is indicated for the treatment of esophageal stenosis, including benign refractory strictures, malignant strictures, esophago-respiratory fistula, and for maintaining esophageal lumenal patency caused by intrinsic or extrinsic tumors.
 

- The results were presented at the Digestive Disease Week® (DDW®) meeting in Los Angeles.
 

www.bostonscientific.com

 
Subscribe to Gastroenterology Newsletter
E-mail Address:

 

About Digestive Disease Week®
Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Society for Surgery of the Alimentary Tract, DDW takes place May 20 - 25, 2006, in Los Angeles. The meeting showcases approximately 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. Boston Scientific is exhibiting at booth #1227 at the conference.

About Boston Scientific
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.
This press release contains forward-looking statements. Boston Scientific wishes to caution the reader of this press release that actual results may differ from those discussed in the forward-looking statements and may be adversely affected by, among other things, risks associated with new product development and commercialization, clinical trials, intellectual property, regulatory approvals, competitive offerings, integration of acquired companies, Boston Scientific’s overall business strategy, and other factors described in Boston Scientific’s filings with the Securities and Exchange Commission.


Related Gastroenterology News

British scientists create artificial stomach
Researchers find a gene variant that protects against development of IBD
MR Elastography may help in early diagnosis of liver fibrosis
Lactose intolerance does not mean total avoidance of dairy foods
Why does prolonged IV feeding damage the liver?
Oral enzyme therapy for celiac sprue may mean less dietary restrictions
Coffee may reduce risk of alcoholic cirrhosis
Benefits of Polyflex Esophageal Stents For Treating Refractory Benign Esophageal Strictures
Novel visualization by SpyGlass System may reduce repeat ERCP procedures
Endoscopic clips useful in patients on coumadin anticoagulation therapy undergoing colonoscopy


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us